I-131 therapy for metastatic thyroid cancer with recombinant human thyroid-stimulating hormone (Thyrogen)
Not Applicable
- Conditions
- Thyroid cancer
- Registration Number
- JPRN-UMIN000013970
- Lead Sponsor
- Asahikawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) a patient whose thyroid Ca has not able to uptake I-131 2) a patient with clitical disease 3) a patient who was administered an iodinated contrast agent 4) pregnant female and feeding female 5) when medical staff determine that treatment can not be properly carried out
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method